KioMedine Injections
Kiomedine is a single injection treatment for osteoarthritis.
Benefits of KioMedine
KioMedinevsone is a unique fluid implant indicated for the symptomatic treatment of knee osteoarthritis with a single intraarticular injection. KioMedinevsone is based on a world-first, exclusive, animal-free KioMedine® (CM) Carboxymethyl-Chitosan. KiOmedine® CM-Chitosan is a highly purified polysaccharide derived from Agaricus Bisporus (button mushroom) resulting from years of research and innovation and is a patented technology by KiOmed Pharma in Belgium.
Thanks to a unique structure that differs from natural chitosan, CM-Chitosan provides to KioMedinevsone an exclusive dual mechanism of action to tackle osteoarthritis pain and other symptoms by enhancing joint lubrication and by reducting oxidative stress.
In our Clinic we use Kiomedine for patients who are refractory or resistant to Hyaluronic acid and PRP injections and typically for those who do not wish to or unlikely responders to proceed with Arthrosamid injections. Kiomedine can offer 9-12 months of relief with a single injection and studies have shown high responder rates in patients with grade 3-4 osteoarthritis who are eligible for total knee replacements.
